Iris Kleerekooper
Impact in
- Ophthalmology top 10%
-
- Plant-based Medicinal Research
Papers in
-
- Multiple Sclerosis Research Studies 4
-
- Glaucoma and retinal disorders 3
- Retinal Diseases and Treatments 2
- Retinal and Optic Conditions 2
- Co-authors
- René S. Kahn (2 shared papers)Wery P. M. van den Wildenberg (2 shared papers)Matthijs Vink (2 shared papers)Suze A. Jansen (1 shared paper)Anna Stary‐Weinzinger (1 shared paper)Marcel A. G. van der Heyden (1 shared paper)Zonne L. M. Hofman (1 shared paper)S. Anand Trip (7 shared papers)
- Journals
- Multiple Sclerosis and Related Disorders (1 paper)British Journal of Ophthalmology (1 paper)Neurology Neuroimmunology & Neuroinflammation (1 paper)NeuroImage (1 paper)Brain (1 paper)
- Partner nations
- NetherlandsUnited KingdomGermany
In The Last Decade
Iris Kleerekooper
12 papers receiving 311 citations
Peers
Comparison fields: 5 of 72
- Ophthalmology 38
- Pharmacology 36
- Pathology and Forensic Medicine 74
- General Decision Sciences 7
- Cognitive Neuroscience 68
Countries citing papers authored by Iris Kleerekooper
This map shows the geographic impact of Iris Kleerekooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris Kleerekooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris Kleerekooper more than expected).
Fields of papers citing papers by Iris Kleerekooper
This network shows the impact of papers produced by Iris Kleerekooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris Kleerekooper. The network helps show where Iris Kleerekooper may publish in the future.
Co-authors
The 25 scholars most cited alongside Iris Kleerekooper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 98 | |
| 2 | 2016 | 44 | |
| 3 | 2015 | 41 | |
| 4 | 2020 | 32 | |
| 5 | 2018 | 27 | |
| 6 | 2020 | 21 | |
| 7 | 2020 | 17 | |
| 8 | 2019 | 13 | |
| 9 | 2017 | 12 | |
| 10 | 2022 | 6 | |
| 11 | Risk of false negative JC virus PCR in CSF of natalizumab-associated PML patients reflects low PML lesion volume. | 2016 | 3 |
| 12 | 2023 | 2 | |
| 13 | 2024 | 0 | |
| 14 | 2020 | 0 |
About Iris Kleerekooper
Iris Kleerekooper is a scholar working on Pathology and Forensic Medicine, Ophthalmology, Molecular Biology, Rheumatology and Neurology, having authored 14 papers that have together received 316 indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (4 papers), Glaucoma and retinal disorders (3 papers), Polyomavirus and related diseases (2 papers), Peripheral Neuropathies and Disorders (2 papers), Neural and Behavioral Psychology Studies (2 papers), Systemic Lupus Erythematosus Research (2 papers), Retinal Diseases and Treatments (2 papers) and Retinal and Optic Conditions (2 papers). The work is most often cited by research in Ophthalmology (38 citations), Pharmacology (36 citations), Pathology and Forensic Medicine (74 citations), General Decision Sciences (7 citations) and Cognitive Neuroscience (68 citations). Iris Kleerekooper has collaborated with scholars based in Netherlands, United Kingdom and Germany. Frequent co-authors include René S. Kahn, Wery P. M. van den Wildenberg, Matthijs Vink, Suze A. Jansen, Anna Stary‐Weinzinger, Marcel A. G. van der Heyden, Zonne L. M. Hofman, S. Anand Trip, Axel Petzold and Sanne J.H. van Rooij. Their work appears in journals such as Multiple Sclerosis and Related Disorders, British Journal of Ophthalmology, Neurology Neuroimmunology & Neuroinflammation, NeuroImage and Brain.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.